Candesartan Cilexetil Drug Market Growth Outlook Reveals A CAGR Of 5.5% And A Market Value Of $2.15 Billion By 2030
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Candesartan Cilexetil Drug Market Forecast: What Market Value Is Expected By 2030?
The candesartan cilexetil market has undergone robust expansion over the past few years. Its valuation is projected to rise from $1.65 billion in 2025 to $1.74 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.4%. Several factors contributed to this historical upswing, including a growing number of hypertension cases, the proven therapeutic effectiveness of angiotensin receptor blockers, a noticeable transition away from ACE inhibitors, broader cardiovascular management protocols, and an increasingly aging demographic.
The candesartan cilexetil drug market is predicted to experience robust expansion in the coming years, reaching a valuation of $2.15 billion by 2030, with a compound annual growth rate (CAGR) of 5.5%. This growth during the forecast period is driven by factors such as the rising prevalence of chronic cardiovascular diseases, greater availability of generic medications, increased use of combination therapies, enhanced healthcare access in emerging markets, and a growing emphasis on preventive cardiovascular care. Key trends influencing the market include the growing application of angiotensin receptor blockers for hypertension management, a higher number of prescriptions for heart failure treatment, a rising demand for affordable generic blood pressure drugs, an expansion in the development of combined treatment formulations, and better patient compliance driven by the convenience of once-daily dosing.
Download A Free Sample Report For Comprehensive Market Insights:
Candesartan Cilexetil Drug Market Growth Momentum: Which Factors Are Influencing Demand?
The anticipated expansion of the candesartan cilexetil drug market is being driven forward by the increasing incidence of cardiovascular disorders. These conditions, which impact the heart or blood vessels and impede proper cardiac function, are becoming more common largely due to sedentary lifestyles that foster obesity, elevated blood pressure, and compromised cardiovascular health by diminishing circulatory efficiency. Candesartan cilexetil addresses these disorders by decreasing blood pressure and alleviating cardiac strain, thereby lowering the likelihood of severe outcomes like heart failure, stroke, or kidney impairment. As an example, data from the British Heart Foundation, a UK cardiovascular research charity, released in January 2025 indicated that approximately 7.6 million people in the UK—comprising about 4 million men and 3.6 million women—were living with heart and circulatory diseases. These ailments account for nearly 27% of all deaths in the nation, leading to over 170,000 fatalities annually, or roughly 480 deaths each day. Consequently, the rising prevalence of cardiovascular disorders is fueling growth in the candesartan cilexetil drug market.
Candesartan Cilexetil Drug Market Segment Breakdown: Which Categories Generate The Most Revenue?
The candesartan cilexetil drug market covered in this report is segmented –
1) By Product Type: Tablets, Capsules, Other Product Types
2) By Indication: Hypertension, Heart Failure, Diabetic Nephropathy, Left Ventricular Hypertrophy
3) By Dosage Strength: 4 MG, 8 MG, 16 MG, 32 MG
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Healthcare Facilities
5) By Application: Adult, Children And Adolescent
Subsegments:
1) By Tablets: Immediate-Release Tablets, Extended-Release Tablets, Dispersible Tablets, Chewable Tablets
2) By Capsules: Hard Gelatin Capsules, Soft Gelatin Capsules, Modified-Release Capsules
3) By Other Product Types: Oral Suspensions, Injectable Formulations, Combination Drug Formulations
Candesartan Cilexetil Drug Market Trends Reshaping Industry Growth
Leading players in the candesartan cilexetil market are concentrating on creating novel formulations, including hypertension treatments, combination products with other blood pressure-lowering agents, and sustained-release versions, designed to boost patient compliance and improve treatment results. Hypertension management involves utilizing medications, adopting lifestyle adjustments, and implementing various measures to lower and regulate high blood pressure, thereby diminishing the likelihood of complications like heart disease, stroke, and kidney impairment. To illustrate, in March 2025, Scienture Inc., a pharmaceutical firm based in the United States, obtained approval from the US Food & Drug Administration (USFDA) for its New Drug Application (NDA) for SCN-102, which was introduced under the brand name Arbli, a losartan potassium oral suspension at a concentration of 10 mg/mL. This angiotensin II receptor blocker (ARB) formulation provides an option for individuals who face challenges with swallowing tablets, especially within pediatric and geriatric groups. This launch highlights the rising interest in alternative delivery formats within the antihypertensive market and emphasizes the movement toward customized, patient-centric therapeutic approaches.
Candesartan Cilexetil Drug Market Key Players And Strategic Industry Positioning
Major companies operating in the candesartan cilexetil drug market are Merck & Co. Inc., Bayer AG, Novartis AG, AstraZeneca plc, GSK plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Sandoz Group AG, Viatris Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Limited, Cipla Limited, Zydus Lifesciences Ltd., Hetero Drugs Limited, Torrent Pharmaceuticals Limited, Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Limited, Oubari Pharmaceutical Co.
Access The Complete Candesartan Cilexetil Drug Market Report:
Candesartan Cilexetil Drug Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the candesartan cilexetil drug market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the candesartan cilexetil drug market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
